{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:37:14Z","timestamp":1782301034208,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.medmal.2011.09.016","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T05:11:02Z","timestamp":1320469862000},"page":"639-645","source":"Crossref","is-referenced-by-count":79,"title":["Phototoxicity and photocarcinogenesis associated with voriconazole"],"prefix":"10.1016","volume":"41","author":[{"given":"O.","family":"Epaulard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-T.","family":"Leccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Blanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-F.","family":"Mamzer-Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Villier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2011.09.016_bib0005","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.medmal.2011.09.016_bib0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2011.09.016_bib0020","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00286-10","article-title":"International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole","volume":"54","author":"Lortholary","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2011.09.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007)","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2011.09.016_bib0030","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2011.09.016_bib0035","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0040","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcf.2005.05.019","article-title":"Voriconazole therapy in children with cystic fibrosis","volume":"4","author":"Hilliard","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.medmal.2011.09.016_bib0055","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1128\/AAC.46.8.2546-2553.2002","article-title":"Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens","volume":"46","author":"Purkins","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2011.09.016_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2125.2003.01993.x","article-title":"Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety","volume":"56","author":"Purkins","year":"2003","journal-title":"British J Clin Pharmacol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0065","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/522973","article-title":"An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis","volume":"45","author":"Queiroz-Telles","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jinf.2007.07.003","article-title":"A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)","volume":"55","author":"Vehreschild","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2011.09.016_bib0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12185-008-0045-z","article-title":"Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole","volume":"87","author":"Vehreschild","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"Ped Infect Dis J"},{"key":"10.1016\/j.medmal.2011.09.016_bib0085","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.medmal.2011.09.016_bib0090","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3324\/haematol.2009.020073","article-title":"Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study","volume":"95","author":"Cordonnier","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.medmal.2011.09.016_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.11.028","article-title":"Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis","volume":"119","author":"Sambatakou","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.medmal.2011.09.016_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00520-009-0783-3","article-title":"Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome","volume":"19","author":"Mattiuzzi","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.medmal.2011.09.016_bib0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0609.2009.01367.x","article-title":"Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia","volume":"84","author":"Torres","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-3062.2009.00455.x","article-title":"Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Martin","year":"2010","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.medmal.2011.09.016_bib0120","article-title":"Voriconazole vs. itraconazole for primary prophylaxis of invasive fungal infection in allogeneic hematopoietic cell transplant recipients","author":"Marks","year":"2009","journal-title":"ICAAC"},{"key":"10.1016\/j.medmal.2011.09.016_bib0125","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1751-1097.1995.tb02392.x","article-title":"fluoroquinolones sensitization: a review of clinical and laboratories studies","volume":"62","author":"Ferguson","year":"1995","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0151-9638(06)70910-3","article-title":"Photosensibilisation au voriconazole: 7\u00a0cas","volume":"133","author":"Auffret","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/QAD.0b013e3282f706a9","article-title":"Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy","volume":"22","author":"Brunel","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.medmal.2011.09.016_bib0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ppul.21234","article-title":"Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?","volume":"45","author":"Cheng","year":"2010","journal-title":"Ped Pulmonol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0145","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/375235","article-title":"Successful treatment of coccidioidal meningitis with voriconazole","volume":"36","author":"Cortez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaad.2009.09.033","article-title":"Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole","volume":"62","author":"Cowen","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0155","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2230.2001.00909.x","article-title":"Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole","volume":"26","author":"Denning","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-4632.2004.02177.x","article-title":"Pseudoporphyria as a result of voriconazole use: a cases report","volume":"43","author":"Dolan","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0165","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1469-0691.2009.03124.x","article-title":"Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients","volume":"16","author":"Epaulard","year":"2010","journal-title":"Clin Microbiol Inf"},{"key":"10.1016\/j.medmal.2011.09.016_bib0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/INF.0b013e3181d60a82","article-title":"Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole","volume":"29","author":"Frick","year":"2010","journal-title":"Ped Infect Dis J"},{"key":"10.1016\/j.medmal.2011.09.016_bib0175","first-page":"562","article-title":"X-linked chronic granulomatous disease with voriconazole-induced photosensitivity\/photoaging reaction","volume":"9","author":"Frisch","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.annder.2009.10.179","article-title":"Porphyrie cutan\u00e9e tardive r\u00e9v\u00e9l\u00e9e par le voriconazole","volume":"137","author":"Hickman","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0185","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1524-4725.2010.01596.x","article-title":"Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole","volume":"36","author":"Ibrahim","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.medmal.2011.09.016_bib0190","first-page":"1042","article-title":"Pseudoporphyria associated with voriconazole","volume":"6","author":"Kwong","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3121\/cmr.2008.806","article-title":"Voriconazole-induced photosensitivity","volume":"6","author":"Malani","year":"2008","journal-title":"Clin Med Res"},{"key":"10.1016\/j.medmal.2011.09.016_bib0200","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1086\/511685","article-title":"Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy","volume":"44","author":"McCarthy","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archdermatol.2009.362","article-title":"Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity","volume":"146","author":"Miller","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0210","doi-asserted-by":"crossref","first-page":"351084","DOI":"10.1155\/2010\/351084","article-title":"Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a cases report","volume":"2010","author":"Morice","year":"2010","journal-title":"Case Rep Med"},{"key":"10.1016\/j.medmal.2011.09.016_bib0215","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbmt.2008.12.491","article-title":"Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients","volume":"15","author":"Patel","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.medmal.2011.09.016_bib0220","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.jaad.2004.07.034","article-title":"Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl","volume":"52","author":"Racette","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D352H3F976","article-title":"Voriconazole-associated phototoxicity","volume":"17","author":"Riahi","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.medmal.2011.09.016_bib0230","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.0736-8046.2004.21614.x","article-title":"Voriconazole-induced retinoid-like photosensitivity in children","volume":"21","author":"Rubenstein","year":"2004","journal-title":"Ped Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0235","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1130-6343(06)74012-0","article-title":"Voriconazole-associated phototoxicity","volume":"30","author":"Serra Soler","year":"2006","journal-title":"Farmac Hospit"},{"key":"10.1016\/j.medmal.2011.09.016_bib0240","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaad.2005.03.030","article-title":"Pseudoporphyria induced by voriconazole","volume":"53","author":"Sharp","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0781.2007.00263.x","article-title":"Voriconazole-induced pseudoporphyria","volume":"23","author":"Tolland","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.medmal.2011.09.016_bib0250","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1600-6143.2007.02140.x","article-title":"Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient","volume":"8","author":"Vanacker","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.medmal.2011.09.016_bib0255","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10096-004-1176-7","article-title":"Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole","volume":"23","author":"Vandecasteele","year":"2004","journal-title":"Eur J Clin Microbiol Inf Dis"},{"key":"10.1016\/j.medmal.2011.09.016_bib0260","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1610-0387.2010.07563.x","article-title":"Severe phototoxicity associated with long-term voriconazole treatment","volume":"9","author":"Vohringer","year":"2011","journal-title":"J Germ Soc Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0265","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1345\/aph.1H671","article-title":"Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database","volume":"41","author":"Eiden","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.medmal.2011.09.016_bib0270","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/annonc\/mdj126","article-title":"Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy","volume":"17","author":"Curigliano","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0275","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/01.SMJ.0000144618.80128.F9","article-title":"Toxic epidermal necrolysis as a complication of treatment with voriconazole","volume":"97","author":"Huang","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.medmal.2011.09.016_bib0280","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaad.2005.08.069","article-title":"Voriconazole-induced blistering in the setting of graft versus host disease: a report of 2 patients","volume":"58","author":"Conlon","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0285","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10227-005-0017-3","article-title":"Photosensitivity to exogenous agents","volume":"8","author":"Lankerani","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.medmal.2011.09.016_bib0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002018-200225050-00004","article-title":"Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management","volume":"25","author":"Moore","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.medmal.2011.09.016_bib0295","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-123-5-199509010-00006","article-title":"Alopecia associated with fluconazole therapy","volume":"123","author":"Pappas","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2011.09.016_bib0300","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003088-200645070-00002","article-title":"Pharmacokinetic\/pharmacodynamic profile of voriconazole","volume":"45","author":"Theuretzbacher","year":"2006","journal-title":"Clin Pharmacokin"},{"key":"10.1016\/j.medmal.2011.09.016_bib0305","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2125.2009.03534.x","article-title":"Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype","volume":"68","author":"Scholz","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0310","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.bcp.2007.03.012","article-title":"Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes","volume":"73","author":"Murayama","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0315","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(95)00213-J","article-title":"Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia","volume":"50","author":"Schwartz","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.medmal.2011.09.016_bib0320","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/j.healun.2008.11.514","article-title":"Voriconazole use increases the incidence of skin cancer in lung transplant recipients","volume":"28","author":"Feist","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.medmal.2011.09.016_bib0325","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.healun.2010.05.022","article-title":"Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients","volume":"29","author":"Vadnerkar","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.medmal.2011.09.016_bib0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1011-1344(96)07424-6","article-title":"Fluoroquinolone antibacterials enhance UVA-induced skin tumors","volume":"37","author":"Klecak","year":"1997","journal-title":"J Photochem Photobiol"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X11002940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X11002940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T22:16:14Z","timestamp":1639520174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X11002940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0399077X11002940"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2011.09.016","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}